Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

MLA

Vallabh, Sonia M., et al. “Prion Protein Quantification in Human Cerebrospinal Fluid as a Tool for Prion Disease Drug Development.” Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 16, Apr. 2019, pp. 7793–98. EBSCOhost, https://doi.org/10.1073/pnas.1901947116.

APA

Vallabh, S. M., Nobuhara, C. K., Llorens, F., Zerr, I., Parchi, P., Capellari, S., Kuhn, E., Klickstein, J., Safar, J. G., Nery, F. C., Swoboda, K. J., Geschwind, M. D., Zetterberg, H., Arnold, S. E., Minikel, E. V., & Schreiber, S. L. (2019). Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proceedings of the National Academy of Sciences of the United States of America, 116(16), 7793–7798. https://doi.org/10.1073/pnas.1901947116

Chicago

Vallabh, Sonia M, Chloe K Nobuhara, Franc Llorens, Inga Zerr, Piero Parchi, Sabina Capellari, Eric Kuhn, et al. 2019. “Prion Protein Quantification in Human Cerebrospinal Fluid as a Tool for Prion Disease Drug Development.” Proceedings of the National Academy of Sciences of the United States of America 116 (16): 7793–98. doi:10.1073/pnas.1901947116.